JPMorgan Chase & Co. Lowers Stake in Trupanion, Inc. $TRUP

JPMorgan Chase & Co. lessened its position in Trupanion, Inc. (NASDAQ:TRUP) by 52.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 77,649 shares of the financial services provider’s stock after selling 84,132 shares during the period. JPMorgan Chase & Co. owned about 0.18% of Trupanion worth $3,361,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Voya Investment Management LLC grew its stake in Trupanion by 2.4% in the 3rd quarter. Voya Investment Management LLC now owns 10,379 shares of the financial services provider’s stock worth $449,000 after acquiring an additional 243 shares during the period. Thrivent Financial for Lutherans boosted its holdings in shares of Trupanion by 1.1% during the second quarter. Thrivent Financial for Lutherans now owns 24,853 shares of the financial services provider’s stock worth $1,376,000 after purchasing an additional 282 shares during the last quarter. EP Wealth Advisors LLC boosted its holdings in shares of Trupanion by 2.9% during the second quarter. EP Wealth Advisors LLC now owns 10,310 shares of the financial services provider’s stock worth $571,000 after purchasing an additional 292 shares during the last quarter. New York State Common Retirement Fund grew its position in shares of Trupanion by 0.4% in the second quarter. New York State Common Retirement Fund now owns 83,930 shares of the financial services provider’s stock valued at $4,646,000 after purchasing an additional 296 shares during the period. Finally, AdvisorNet Financial Inc grew its position in shares of Trupanion by 2.5% in the third quarter. AdvisorNet Financial Inc now owns 14,210 shares of the financial services provider’s stock valued at $615,000 after purchasing an additional 350 shares during the period.

Insider Transactions at Trupanion

In other Trupanion news, CRO Emily Dreyer sold 7,792 shares of Trupanion stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $28.15, for a total transaction of $219,344.80. Following the transaction, the executive directly owned 35,627 shares of the company’s stock, valued at $1,002,900.05. The trade was a 17.95% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, COO John R. Gallagher sold 5,283 shares of the business’s stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $26.52, for a total transaction of $140,105.16. Following the sale, the chief operating officer owned 32,387 shares of the company’s stock, valued at approximately $858,903.24. This represents a 14.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 21,502 shares of company stock worth $580,315. 5.42% of the stock is currently owned by company insiders.

Trupanion Stock Performance

Shares of TRUP opened at $25.65 on Friday. Trupanion, Inc. has a twelve month low of $24.32 and a twelve month high of $57.88. The firm has a market capitalization of $1.11 billion, a P/E ratio of 57.00 and a beta of 1.66. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.27. The stock’s fifty day simple moving average is $28.18 and its 200 day simple moving average is $35.13.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings results on Thursday, February 12th. The financial services provider reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.01). The firm had revenue of $376.85 million for the quarter, compared to analysts’ expectations of $375.89 million. Trupanion had a net margin of 1.35% and a return on equity of 5.39%. Trupanion’s revenue was up 11.7% on a year-over-year basis. During the same period last year, the firm posted $0.04 EPS. On average, equities research analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Analyst Ratings Changes

TRUP has been the topic of several recent analyst reports. Piper Sandler reduced their target price on Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a research report on Friday, February 13th. Cantor Fitzgerald dropped their price objective on shares of Trupanion from $50.00 to $42.00 and set a “neutral” rating for the company in a research note on Wednesday, January 14th. Stifel Nicolaus cut their price objective on shares of Trupanion from $35.00 to $31.00 and set a “hold” rating on the stock in a report on Tuesday, March 31st. Wall Street Zen cut shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Finally, Zacks Research downgraded shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Friday, February 13th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $44.50.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.